Clinical Trials
6 trialsNCT06136650 2026-06-03
MK-5684-004
Merck Sharp & Dohme LLC
Phase 3 Recruiting
NCT06104449 2026-04-27
MK-5684-005
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT06136598 2026-03-19
MK-5684-001
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT05974410 2025-10-02
Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
AVM Biotechnology Inc
Available
NCT00181597 2013-12-03
Trilostane for Androgen-Independent Prostate Cancer
Sanofi
Phase 2 Completed
NCT00705822 2010-11-30
PROSTATA
Sanofi
Phase 3 Terminated